AI
-
5 AI takeaways from AdvaMed’s conference
Medical device firms discussed privacy, regulations and prioritizing projects as AI becomes more prevalent in the industry.
By Elise Reuter • Oct. 14, 2025 -
Intuitive expands AI in Ion; Horizon performs first robotic cataract surgery
The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract surgery with its robotic system, and MMI began a neurosurgical study.
By Susan Kelly • Oct. 10, 2025 -
Explore the Trendline➔
Permission granted by Boston ScientificTrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
How 4 medtech CEOs are using AI
At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use the technology internally is challenging.
By Elise Reuter • Oct. 7, 2025 -
Q&A
Hospital for Special Surgery’s Ashis Barad says AI must solve real problems
Barad, chief digital and technology officer at HSS, outlined his approach to evaluating AI tools and how the orthopedic hospital uses the technology.
By Elise Reuter • Oct. 3, 2025 -
CDRH shares regulatory guidance priorities for the coming 12 months
Use of real-world evidence to support regulatory decisions and predetermined change control plans for medical devices are two areas of focus for the agency.
By Nick Paul Taylor • Oct. 2, 2025 -
Deep Dive
AI could transform healthcare. Can safety-net providers keep up?
Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a digital divide between highly resourced health systems and safety-net providers.
By Emily Olsen • Oct. 2, 2025 -
FDA seeks feedback on monitoring real-world performance of AI devices
The agency is looking for ways to detect, assess and mitigate changes to the performance of AI-enabled devices over time.
By Nick Paul Taylor • Oct. 1, 2025 -
Heartflow receives FDA clearance for updated plaque analysis platform
The updated algorithm shows a 21% improvement in plaque detection, compared to the original version.
By Nick Paul Taylor • Sept. 25, 2025 -
Deep Dive
How three companies are using foundation models in radiology
Some firms, such as Aidoc, are working directly with the FDA. Others, such as HOPPR, are offering their foundation models for medtech companies to build their own AI tools.
By Elise Reuter • Sept. 16, 2025 -
Deep Dive
Foundation models are medtech’s newest trend. But what are they?
The AI models, which are built on massive datasets and can be adapted to multiple tasks, have become a part of medtech companies’ lexicon in the past few years.
By Elise Reuter • Sept. 15, 2025 -
AI drives medtech investment in 2025
Medical device companies working with artificial intelligence raised funding and were acquisition targets in recent months.
By Elise Reuter • Sept. 12, 2025 -
GE HealthCare inks Icometrix buyout to acquire brain MRI software
The deal includes AI-powered software for detecting known side effects of recently launched Alzheimer’s drugs.
By Nick Paul Taylor • Sept. 11, 2025 -
AI firm Ketryx raises $39M, adds former Medtronic CEO as investor
The company, which helps medtech companies with AI compliance, has raised more than $55 million to date.
By Elise Reuter • Sept. 5, 2025 -
AI devices with no clinical validation tied to more recalls, study finds
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.
By Elise Reuter • Sept. 2, 2025 -
Medtech VC funding on track to hit highest value since 2021: PitchBook
“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.
By Nick Paul Taylor • Sept. 2, 2025 -
Tempus inks $81M Paige buyout to support AI model development
CEO Eric Lefkofsky said that buying Paige “substantially accelerates” Tempus’ effort to build the largest foundation model in oncology.
By Nick Paul Taylor • Aug. 26, 2025 -
Philips will spend $150M to expand manufacturing for AI-enabled tech
The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, facility.
By Elise Reuter • Aug. 15, 2025 -
Oracle launches AI-backed EHR
The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.
By Emily Olsen • Aug. 14, 2025 -
Q&A
Shan Jegatheeswaran shares J&J’s vision for AI in the OR
By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in procedures.
By Elise Reuter • Aug. 13, 2025 -
Cardiosense appoints John Martin as chief medical officer
The appointment comes weeks after the company received 510(k) clearance for its wearable heart monitor.
By Nick Paul Taylor • Aug. 13, 2025 -
Cardiosense wins FDA clearance for wearable heart monitor
The device captures various types of heart data that could be used in AI models for cardiovascular parameters with the aim of lowering barriers to monitoring.
By Nick Paul Taylor • July 31, 2025 -
Health tech investment bolstered by AI in H1: report
Venture capital investment across the healthcare sector slowed in the first half of the year, but investors are spending on health tech — especially artificial intelligence, according to a report by Silicon Valley Bank.
By Emily Olsen • July 29, 2025 -
Trump administration releases AI adoption plan
AdvaMed CEO Scott Whitaker said the medtech lobbying group looks forward to working on policies that will unleash “the full potential of AI to help make America healthy again.”
By Emily Olsen • July 25, 2025 -
Aidoc raises $150M for AI foundation model
The technology, called CARE, is expected to allow for faster development of AI models that can cover more health conditions.
By Elise Reuter • July 24, 2025 -
Carlsmed seeks up to $103M IPO haul to fuel spine surgery growth
The company’s custom implants compete with devices from Medtronic, Johnson & Johnson and Globus Medical.
By Nick Paul Taylor • July 18, 2025